SCM
BIIB icon

Stux Capital Management’s Biogen BIIB Stock Holding History

Stux Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$2.9M Sell
9,200
-1,900
-17% -$572K 0.38% 70
2014
Q1 		$3.4M Sell
11,100
-500
-4% -$159K 0.42% 65
2013
Q4 		$3.24M Buy
11,600
+100
+0.9% +$25.9K 0.39% 74
2013
Q3 		$2.77M Sell
11,500
-1,300
-10% -$291K 0.37% 76
2013
Q2 		$2.75M Buy
+12,800
New +$2.74M 0.35% 71

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stux Capital Management's BIIB Position: Q2 2014 in Review

Stux Capital Management reduced its Biogen (BIIB) stake by 17% in Q2 2014, selling an estimated $572K and leaving 9,200 shares worth $2.9M. The position accounts for 0.38% of the portfolio, ranked #70.

Stux Capital Management first reported a position in BIIB in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.4M in Q1 2014. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • Stux Capital Management held 9,200 shares of Biogen worth $2.9M as of Q2 2014.
  • Stux Capital Management sold 1,900 Biogen shares in Q2 2014, an estimated $572K.
  • Biogen made up 0.38% of Stux Capital Management's portfolio in Q2 2014, its #70 holding.
  • Stux Capital Management first reported a position in Biogen in Q2 2013 and has held it in 5 quarters since.
  • Stux Capital Management's Biogen position peaked at $3.4M in Q1 2014.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.